Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4SANOFI-AVENTIS CANADA INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Prescription

Registration Country : Canada

DUPILUMAB

Brand Name : DUPIXENT

Dosage Form : SOLUTION

Dosage Strength : 200MG/1.14ML

Packaging :

Approval Date :

Application Number : 2492504

Regulatory Info : Prescription

Registration Country : Canada

Sanofi Company Banner

02

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Prescription

Registration Country : Canada

DUPILUMAB

Brand Name : DUPIXENT

Dosage Form : SOLUTION

Dosage Strength : 200MG/1.14ML

Packaging :

Approval Date :

Application Number : 2524252

Regulatory Info : Prescription

Registration Country : Canada

Sanofi Company Banner

03

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Prescription

Registration Country : Canada

DUPILUMAB

Brand Name : DUPIXENT

Dosage Form : SOLUTION

Dosage Strength : 300MG/2ML

Packaging : 2ML

Approval Date :

Application Number : 2470365

Regulatory Info : Prescription

Registration Country : Canada

Sanofi Company Banner

04

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Prescription

Registration Country : Canada

DUPILUMAB

Brand Name : DUPIXENT

Dosage Form : SOLUTION

Dosage Strength : 300MG/2ML

Packaging :

Approval Date :

Application Number : 2510049

Regulatory Info : Prescription

Registration Country : Canada

Sanofi Company Banner